A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies.
Schelman WR; Traynor AM; Holen KD; Kolesar JM; Attia S; Hoang T; Eickhoff J; Jiang Z; Alberti D; Marnocha R; Reid JM; Ames MM; McGovern RM; Espinoza-Delgado I; Wright JJ; Wilding G; Bailey HH; Investigational New Drugs, 2013, vol. 31, issue 6, p 1539, ISSN 15730646. ISBN 15730646.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef